Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Omar Al-Nouri

Vascular Surgery La Jolla, CA Doctor of Osteopathy

NPI 1770742264 CMS profile 306996

9898 Genesee Ave, La Jolla, CA 92037

Open in the dashboard

General payments

$58,311

381 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Omar Al-Nouri of La Jolla, CA is reported in the CMS Open Payments database as having received $58,311 across 381 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,530 103
2024 General $23,639 77
2023 General $7,650 46
2022 General $6,511 56
2021 General $4,542 41
2020 General $4,452 32
2019 General $1,987 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Omar Al-Nouri
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Omar Al-Nouri were reported at $9,530. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Omar Al-Nouri Vascular Surgery median Middle half National median
2019 $1,987 $796 $226–$2,363 $163
2020 $4,452 $348 $118–$1,110 $114
2021 $4,542 $471 $158–$1,421 $132
2022 $6,511 $725 $222–$2,183 $149
2023 $7,650 $836 $257–$2,440 $160
2024 $23,639 $909 $252–$2,619 $164
2025 $9,530 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cardiovascular Systems Inc. $12,647 30 payments
  2. Cook Incorporated $12,400 2 payments
  3. Philips Electronics North America Corporation $7,437 16 payments
  4. Endologix, Inc. $7,375 55 payments
  5. Cook Medical LLC $4,290 71 payments
  6. Silk Road Medical, Inc. $3,234 33 payments
  7. W. L. Gore & Associates, Inc. $2,116 38 payments
  8. Medtronic, Inc. $1,785 30 payments
  9. Shockwave Medical, Inc $1,321 27 payments
  10. Stryker Corporation $954 5 payments
  11. Other $4,751 74 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $21,795 340 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,400 2 payments
  3. Consulting Fee $11,885 6 payments
  4. Travel and Lodging $6,532 28 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $3,600 2 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,100 3 payments
Products named General payments · program years 2019–2025
  1. ZILVER VENA $12,400 2 payments
  2. Diamondback Peripheral $9,527 19 payments
  3. (9520) IGT Devices Undivided $6,584 8 payments
  4. Alto Abdominal Stent Graft System $4,752 31 payments
  5. ENROUTE Transcarotid Stent $3,165 31 payments
  6. ENROUTE Transcarotid Neuroprotection System $3,165 31 payments
  7. Peripheral Orbital Atherectomy System $3,120 11 payments
  8. AFX2 Bifurcated Endograft System $2,851 17 payments
  9. Ovation iX Iliac Stent Graft $1,265 14 payments
  10. CT THROMBECTOMY SYSTEM KIT $953 5 payments
  11. Other $19,015 281 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 138 billing codes

Paid by Medicare

$178,500

Of which drugs: $255

Medicare patients

499

Average age 73

Services billed

2,223

216 women, 283 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 55%
Chronic kidney disease 54%
Arthritis 53%
Diabetes 49%
Heart failure 43%
Atrial fibrillation 32%
Depression 32%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 32 1,089 $113

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

381 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record